Signalling by insulin and IGF receptors: Supporting acts and new players

Journal of Molecular Endocrinology

Volumn 47, Issue 1, 2011, Pages

  Siddle, Kenneth ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE TRANSPORTER 4; INSULIN; INSULIN RECEPTOR; ISOPROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NUCLEOTIDE PYROPHOSPHATASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN TYROSINE PHOSPHATASE SHP 2; RAS PROTEIN; RHEB PROTEIN; SOMATOMEDIN B; SOMATOMEDIN RECEPTOR;

ALPHA CHAIN; CARBOXY TERMINAL SEQUENCE; GENE LOCUS; INHIBITION KINETICS; INSULIN METABOLISM; LIGAND BINDING; MOLECULAR DYNAMICS; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN ASSEMBLY; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; PROTEOMICS; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; GLUCOSE; HUMANS; INSULIN; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; PROTEIN CONFORMATION; PROTEIN TRANSPORT; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS P21(RAS); RECEPTOR, INSULIN; RECEPTORS, SOMATOMEDIN; SIGNAL TRANSDUCTION;

EID: 79961004321     PISSN: 09525041     EISSN: 14796813     Source Type: Journal    
DOI: 10.1530/JME-11-0022     Document Type: Review

References (125)

1. Adams TE, McKern NM & Ward CW 2004 Signalling by the type 1 insulin-like growth factor receptor: interplay with the epidermal growth factor receptor. Growth Factors 22 89-95. (doi:10.1080/ 08977190410001700998)
2. Ahn MY, Katsanakis KD, Bheda F & Pillay TS 2004 Primary and essential role of the adaptor protein APS for recruitment of both c-Cbl and its associated protein CAP in insulin signaling. Journal of Biological Chemistry 279 21526-21532. (doi:10.1074/jbc. M307740200)
3. Aleksic T, Chitnis MM, Perestenko OV, Gao S, Thomas PH, Turner GD, Protheroe AS, Howarth M & Macaulay VM 2010 Type 1 insulin-like growth factor receptor translocates to the nucleus of human tumor cells. Cancer Research 70 6412-6419. (doi:10.1158/0008-5472.CAN- 10-0052)
4. Avruch J 2007 MAP kinase pathways: the first twenty years. Biochimica et Biophysica Acta 1773 1150-1160. (doi:10.1016/j.bbamcr.2006.11. 006)
5. Belfiore A, Frasca F, Pandini G, Sciacca L & Vigneri R 2009 Insulin receptor isoforms and insulin receptor/insulin-like growth factor receptor hybrids in physiology and disease. Endocrine Reviews 30 586-623. (doi:10.1210/er.2008-0047)
6. Berggreen C, Gormand A, Omar B, Degerman E & Goransson O 2009 Protein kinase B activity is required for the effects of insulin on lipid metabolism in adipocytes. American Journal of Physiology. Endocrinology andMetabolism 296 E635-E646. (doi:10.1152/ajpendo. 90596.2008)
7. Berwick DC, Dell GC, Welsh GI, Heesom KJ, Hers I, Fletcher LM, Cooke FT & Tavare JM 2004 Protein kinase B phosphorylation of PIKfyve regulates the trafficking of GLUT4 vesicles. Journal of Cell Science 117 5985-5993. (doi:10.1242/jcs.01517)
8. Boucher J, Tseng YH & Kahn CR 2010 Insulin and insulin-like growth factor-1 receptors act as ligand-specific amplitude modulators of a common pathway regulating gene transcription. Journal of Biological Chemistry 285 17235-17245. (doi:10.1074/jbc.M110.118620)
9. Boura-Halfon S & Zick Y 2009 Phosphorylation of IRS proteins, insulin action, and insulin resistance. American Journal of Physiology. Endocrinology andMetabolism 296 E581-E591. (doi:10.1152/ajpendo. 90437.2008)
10. Bouskila M, Hunter RW, Ibrahim AF, Delattre L, Peggie M, van Diepen JA, Voshol PJ, Jensen J & Sakamoto K 2010 Allosteric regulation of glycogen synthase controls glycogen synthesis in muscle. Cell Metabolism 12 456-466. (doi:10.1016/j.cmet.2010.10.006)
11. Bouzakri K, Zachrisson A, Al-Khalili L, Zhang BB, Koistinen HA, Krook A & Zierath JR 2006 siRNA-based gene silencing reveals specialized roles of IRS-1/Akt2 and IRS-2/Akt1 in glucose and lipid metabolism in human skeletal muscle. Cell Metabolism 4 89-96. (doi:10.1016/j.cmet. 2006.04.008)
12. Bozulic L & Hemmings BA 2009 PIKKing on PKB: regulation of PKB activity by phosphorylation. Current Opinion in Cell Biology 21 256-261. (doi:10.1016/j.ceb.2009.02.002)
13. Brachmann SM, Ueki K, Engelman JA, Kahn RC & Cantley LC 2005 Phosphoinositide 3-kinase catalytic subunit deletion and regulatory subunit deletion have opposite effects on insulin sensitivity in mice. Molecular and Cellular Biology 25 1596-1607. (doi:10.1128/MCB.25. 5.1596-1607.2005)
14. Brognard J & Newton AC 2008 PHLiPPing the switch on Akt and protein kinase C signaling. Trends in Endocrinology and Metabolism 19 223-230. (doi:10.1016/j.tem.2008.04.001)
15. Bromann PA, Korkaya H & Courtneidge SA 2004 The interplay between Src family kinases and receptor tyrosine kinases. Oncogene 23 7957-7968. (doi:10.1038/sj.onc.1208079)
16. Brown MD & Sacks DB 2009 Protein scaffolds in MAP kinase signalling. Cellular Signalling 21 462-469. (doi:10.1016/j.cellsig.2008.11.013)
17. Chang L, Chiang SH & Saltiel AR 2004 Insulin signaling and the regulation of glucose transport. Molecular Medicine 10 65-71. (doi:10.2119/2005-00029.Saltiel)
18. Chaussade C, Rewcastle GW, Kendall JD, Denny WA, Cho K, Gronning LM, Chong ML, Anagnostou SH, Jackson SP, Daniele N et al. 2007 Evidence for functional redundancy of class IA PI3K isoforms in insulin signalling. Biochemical Journal 404 449-458. (doi:10.1042/ BJ20070003)
19. Chen S, Wasserman DH, MacKintosh C & Sakamoto K 2011 Mice with AS160/TBC1D4-Thr649Ala knockin mutation are glucose intolerant with reduced insulin sensitivity and altered GLUT4 trafficking. Cell Metabolism 13 68-79. (doi:10.1016/j.cmet.2010.12.005)
20. Cheng Z, Tseng Y & White MF 2010 Insulin signaling meets mitochondria in metabolism. Trends in Endocrinology and Metabolism 21 589-598. (doi:10.1016/j.tem.2010.06.005)
21. Choi SM, Tucker DF, Gross DN, Easton RM, DiPilato LM, Dean AS, Monks BR & Birnbaum MJ 2010 Insulin regulates adipocyte lipolysis via an Akt-independent signaling pathway. Molecular and Cellular Biology 30 5009-5020. (doi:10.1128/MCB.00797-10)
22. Choudhary C & Mann M 2010 Decoding signalling networks by mass spectrometry-based proteomics. Nature Reviews. Molecular Cell Biology 11 427-439. (doi:10.1038/nrm2900)
23. Cohen P 2006 The twentieth century struggle to decipher insulin signalling. Nature Reviews. Molecular Cell Biology 7 867-873. (doi:10. 1038/nrm2043)
24. Cohen P & Knebel A 2006 KESTREL: a powerful method for identifying the physiological substrates of protein kinases. Biochemical Journal 393 1-6. (doi:10.1042/BJ20051545)
25. De Meyts P 2008 The insulin receptor: a prototype for dimeric, allosteric membrane receptors? Trends in Biochemical Sciences 33 376-384. (doi:10.1016/j.tibs.2008.06.003)
26. Duan C, Yang H, White MF & Rui L 2004 Disruption of the SH2-B gene causes age-dependent insulin resistance and glucose intolerance. Molecular and Cellular Biology 24 7435-7443. (doi:10.1128/MCB.24. 17.7435-7443.2004)
27. Dube N & Tremblay ML 2005 Involvement of the small protein tyrosine phosphatases TC-PTP and PTP1B in signal transduction and diseases: from diabetes, obesity to cell cycle, and cancer. Biochimica et Biophysica Acta 1754 108-117. (doi:10.1016/j.bbapap. 2005.07.030)
28. Dummler B & Hemmings BA 2007 Physiological roles of PKB/Akt isoforms in development and disease. Biochemical Society Transactions 35 231-235. (doi:10.1042/BST0350231)
29. Dumont JE, Dremier S, Pirson I & Maenhaut C 2002 Cross signaling, cell specificity, and physiology. American Journal of Physiology. Cell Physiology 283 C2-C28. (doi:10.1152/ajpcell.00581.2001)
30. Falasca M & Maffucci T 2009 Rethinking phosphatidylinositol 3-monophosphate. Biochimica et Biophysica Acta 1793 1795-1803. (doi:10.1016/j.bbamcr.2009.10.003)
31. Falasca M, Hughes WE, Dominguez V, Sala G, Fostira F, Fang MQ, Cazzolli R, Shepherd PR, James DE & Maffucci T 2007 The role of phosphoinositide 3-kinase C2alpha in insulin signaling. Journal of Biological Chemistry 282 28226-28236. (doi:10.1074/jbc. M704357200)
32. Farese RV & Sajan MP 2010 Metabolic functions of atypical protein kinase C: good and bad as defined by nutritional status. American Journal of Physiology. Endocrinology and Metabolism 298 E385-E394. (doi:10.1152/ajpendo.00608.2009)
33. Foti M, Moukil MA, Dudognon P & Carpentier JL 2004 Insulin and IGF-1 receptor trafficking and signalling. Novartis Foundation Symposium 262 125-141.
34. Foukas LC, Claret M, Pearce W, Okkenhaug K, Meek S, Peskett E, Sancho S, Smith AJ, Withers DJ & Vanhaesebroeck B 2006 Critical role for the p110alpha phosphoinositide-3-OH kinase in growth and metabolic regulation. Nature 441 366-370. (doi:10.1038/nature04694)
35. Fritsche L, Neukamm SS, Lehmann R, Kremmer E, Hennige AM, Hunder-Gugel A, Schenk M, Haring HU, Schleicher ED & Weigert C 2011 Insulin-induced serine phosphorylation of IRS-2 via Erk1/2 and mTOR: studies on the function of Ser 675 and Ser 907. American Journal of Physiology. Endocrinology and Metabolism 300 E824-E836. (doi:10.1152/ajpendo.00409.2010)
36. Fuss B, Becker T, Zinke I & Hoch M 2006 The cytohesin Steppke is essential for insulin signalling in Drosophila. Nature 444 945-948. (doi:10.1038/nature05412)
37. Garfield AS, Cowley M, Smith FM, Moorwood K, Stewart-Cox JE, Gilroy K, Baker S, Xia J, Dalley JW, Hurst LD et al. 2011 Distinct physiological and behavioural functions for parental alleles of imprinted Grb10. Nature 469 534-538. (doi:10.1038/nature 09651)
38. Giacco F & Brownlee M 2010 Oxidative stress and diabetic complications. Circulation Research 107 1058-1070. (doi:10.1161/ CIRCRESAHA.110.223545)
39. Goldfine ID, Maddux BA, Youngren JF, Reaven G, Accili D, Trischitta V, Vigneri R & Frittitta L 2008 The role of membrane glycoprotein plasma cell antigen 1/ectonucleotide pyrophosphatase phosphodiesterase 1 in the pathogenesis of insulin resistance and related abnormalities. Endocrine Reviews 29 62-75. (doi:10.1210/er.2007- 0004)
40. Goldstein BJ, Mahadev K, Wu X, Zhu L & Motoshima H 2005 Role of insulin-induced reactive oxygen species in the insulin signaling pathway. Antioxidants &Redox Signaling 7 1021-1031. (doi:10.1089/ ars.2005.7.1021)
41. Gonzalez E & McGraw TE 2009 The Akt kinases: isoform specificity in metabolism and cancer. Cell Cycle 8 2502-2508. (doi:10.4161/cc.8. 16.9335)
42. Gureasko J, Galush WJ, Boykevisch S, Sondermann H, Bar-Sagi D, Groves JT & Kuriyan J 2008 Membrane-dependent signal integration by the Ras activator Son of sevenless. Nature Structural and Molecular Biology 15 452-461. (doi:10.1038/nsmb.1418)
43. Hafner M, Schmitz A, Grune I, Srivatsan SG, Paul B, Kolanus W, Quast T, Kremmer E, Bauer I & Famulok M 2006 Inhibition of cytohesins by SecinH3 leads to hepatic insulin resistance. Nature 444 941-944. (doi:10.1038/nature05415)
44. Hanke S & Mann M 2009 The phosphotyrosine interactome of the insulin receptor family and its substrates IRS-1 and IRS-2. Molecular and Cellular Proteomics 8 519-534. (doi:10.1074/mcp.M800407- MCP200)
45. Himpe E & Kooijman R 2009 Insulin-like growth factor-I receptor signal transduction and the Janus kinase/signal transducer and activator of transcription (JAK-STAT) pathway. Biofactors 35 76-81. (doi:10.1002/biof.20)
46. Hirai T & Chida K 2003 Protein kinase Czeta (PKCzeta): activation mechanisms and cellular functions. Journal of Biochemistry 133 1-7. (doi:10.1093/jb/mvg017)
47. Hoehn KL, Hohnen-Behrens C, Cederberg A, Wu LE, Turner N, Yuasa T, Ebina Y & James DE 2008 IRS1-independent defects define major nodes of insulin resistance. Cell Metabolism 7 421-433. (doi:10.1016/ j.cmet.2008.04.005)
48. Holt LJ & Siddle K 2005 Grb10 and Grb14: enigmatic regulators of insulin action - and more? Biochemical Journal 388 393-406. (doi:10. 1042/BJ20050216)
49. Holt LJ, Lyons RJ, Ryan AS, Beale SM, Ward A, Cooney GJ & Daly RJ 2009 Dual ablation of Grb10 and Grb14 in mice reveals their combined role in regulation of insulin signaling and glucose homeostasis. Molecular Endocrinology 23 1406-1414. (doi:10.1210/ me.2008-0386)
50. Hsu MF & Meng TC 2010 Enhancement of insulin responsiveness by nitric oxide-mediated inactivation of protein-tyrosine phosphatases. Journal of Biological Chemistry 285 7919-7928. (doi:10.1074/jbc. M109.057513)
51. Hu J & Hubbard SR 2005 Structural characterization of a novel Cbl phosphotyrosine recognition motif in the APS family of adapter proteins. Journal of Biological Chemistry 280 18943-18949. (doi:10. 1074/jbc.M414157200)
52. Huang SM, Hancock MK, Pitman JL, Orth AP & Gekakis N 2009 Negative regulators of insulin signaling revealed in a genome-wide functional screen. PLoS ONE 4 e6871. (doi:10.1371/journal.pone. 0006871)
53. Ishikura S, Koshkina A & Klip A 2008 Small G proteins in insulin action: Rab and Rho families at the crossroads of signal transduction and GLUT4 vesicle traffic. Acta Physiologica 192 61-74. (doi:10.1111/j.1748-1716.2007.01778.x)
54. JeBailey L, Rudich A, Huang X, Di Ciano-Oliveira C, Kapus A & Klip A 2004 Skeletal muscle cells and adipocytes differ in their reliance on TC10 and Rac for insulin-induced actin remodeling. Molecular Endocrinology 18 359-372. (doi:10.1210/me.2003-0294)
55. Jensen M & De Meyts P 2009 Molecular mechanisms of differential intracellular signaling from the insulin receptor. Vitamins and Hormones 80 51-75. (doi:10.1016/S0083-6729(08)00603-1)
56. Jia S, Liu Z, Zhang S, Liu P, Zhang L, Lee SH, Zhang J, Signoretti S, Loda M, Roberts TM et al. 2008 Essential roles of PI(3)K-p110beta in cell growth, metabolism and tumorigenesis. Nature 454 776-779. (doi:10.1038/nature07091)
57. Johnson C, Crowther S, Stafford MJ, Campbell DG, Toth R & MacKintosh C 2010 Bioinformatic and experimental survey of 14-3-3-binding sites. Biochemical Journal 427 69-78. (doi:10.1042/ BJ20091834)
58. Kiely PA, Baillie GS, Lynch MJ, Houslay MD & O'Connor R 2008 Tyrosine 302 in RACK1 is essential for insulin-like growth factor-I-mediated competitive binding of PP2A and beta1 integrin and for tumor cell proliferation and migration. Journal of Biological Chemistry 283 22952-22961. (doi:10.1074/jbc. M800802200)
59. Kiely PA, Baillie GS, Barrett R, Buckley DA, Adams DR, Houslay MD & O'Connor R 2009 Phosphorylation of RACK1 on tyrosine 52 by c-Abl is required for insulin-like growth factor I-mediated regulation of focal adhesion kinase. Journal of Biological Chemistry 284 20263-20274. (doi:10.1074/jbc.M109.017640)
60. Kiselyov VV, Versteyhe S, Gauguin L & De Meyts P 2009 Harmonic oscillator model of the insulin and IGF1 receptors' allosteric binding and activation. Molecular Systems Biology 5 243. (doi:10.1038/msb.2008.78)
61. Klein AL, Berkaw MN, Buse MG & Ball LE 2009 O-linked N-acetylglucosamine modification of insulin receptor substrate-1 occurs in close proximity to multiple SH2 domain binding motifs. Molecular and Cellular Proteomics 8 2733-2745. (doi:10.1074/mcp. M900207-MCP200)
62. Knight ZA, Gonzalez B, Feldman ME, Zunder ER, Goldenberg DD, Williams O, Loewith R, Stokoe D, Balla A, Toth B et al. 2006 A pharmacological map of the PI3-K family defines a role for p110alpha in insulin signaling. Cell 125 733-747. (doi:10.1016/ j.cell.2006.03.035)
63. Larance M, Ramm G & James DE 2008 The GLUT4 code. Molecular Endocrinology 22 226-233. (doi:10.1210/me.2007-0282)
64. Laviola L, Natalicchio A & Giorgino F 2007 The IGF-I signaling pathway. Current Pharmaceutical Design 13 663-669. (doi:10.2174/ 138161207780249146)
65. Lawrence MC, McKern NM & Ward CW 2007 Insulin receptor structure and its implications for the IGF-1 receptor. Current Opinion in Structural Biology 17 699-705. (doi:10.1016/j.sbi.2007. 07.007)
66. Lebrun P & Van Obberghen E 2008 SOCS proteins causing trouble in insulin action. Acta Physiologica 192 29-36. (doi:10.1111/j.1748- 1716.2007.01782.x)
67. Leibiger IB, Brismar K & Berggren PO 2010a Novel aspects on pancreatic beta-cell signal-transduction. Biochemical and Biophysical Research Communications 396 111-115. (doi:10.1016/j.bbrc.2010.02. 174)
68. Leibiger B, Moede T, Uhles S, Barker CJ, Creveaux M, Domin J, Berggren PO & Leibiger IB 2010b Insulin-feedback via PI3KC2alpha activated PKBalpha/Akt1 is required for glucose-stimulated insulin secretion. FASEB Journal 24 1824-1837. (doi:10.1096/ fj.09-148072)
69. Li M, Ren D, Iseki M, Takaki S & Rui L 2006 Differential role of SH2-B and APS in regulating energy and glucose homeostasis. Endocrinology 147 2163-2170. (doi:10.1210/en.2005-1313)
70. Li S, Brown MS & Goldstein JL 2010 Bifurcation of insulin signaling pathway in rat liver: mTORC1 required for stimulation of lipogenesis, but not inhibition of gluconeogenesis. PNAS 107 3441-3446. (doi:10.1073/pnas.0914798107)
71. Lim J, Zhou M, Veenstra TD & Morrison DK 2010 The CNK1 scaffold binds cytohesins and promotes insulin pathway signaling. Genes and Development 24 1496-1506. (doi:10.1101/gad.1904610)
72. Liu BA, Jablonowski K, Shah EE, Engelmann BW, Jones RB & Nash PD 2010 SH2 domains recognize contextual peptide sequence information to determine selectivity. Molecular and Cellular Proteomics 9 2391-2404. (doi:10.1074/mcp.M110.001586)
73. Loh K, Deng H, Fukushima A, Cai X, Boivin B, Galic S, Bruce C, Shields BJ, Skiba B, Ooms LM et al. 2009 Reactive oxygen species enhance insulin sensitivity. Cell Metabolism 10 260-272. (doi:10. 1016/j.cmet.2009.08.009)
74. Luan B, Zhao J, Wu H, Duan B, Shu G, Wang X, Li D, Jia W, Kang J & Pei G 2009 Deficiency of a beta-arrestin-2 signal complex contributes to insulin resistance. Nature 457 1146-1149. (doi:10. 1038/nature07617)
75. Manning BD & Cantley LC 2007 AKT/PKB, signaling: navigating downstream. Cell 129 1261-1274. (doi:10.1016/j.cell.2007.06.009)
76. Mashima R, Hishida Y, Tezuka T & Yamanashi Y 2009 The roles of Dok family adapters in immunoreceptor signaling. Immunological Reviews 232 273-285. (doi:10.1111/j.1600-065X.2009.00844.x)
77. Meng D, Lv DD & Fang J 2008 Insulin-like growth factor-I induces reactive oxygen species production and cell migration through Nox4 and Rac1 in vascular smooth muscle cells. Cardiovascular Research 80 299-308. (doi:10.1093/cvr/cvn173)
78. Miller ML & Blom N 2009 Kinase-specific prediction of protein phosphorylation sites. Methods in Molecular Biology 527 299-310. (doi:10.1007/978-1-60327-834-8_22)
79. Minami A, Iseki M, Kishi K, Wang M, Ogura M, Furukawa N, Hayashi S, Yamada M, Obata T, Takeshita Y et al. 2003 Increased insulin sensitivity and hypoinsulinemia in APS knockout mice. Diabetes 52 2657-2665. (doi:10.2337/diabetes.52.11.2657)
80. Mitra P, Zheng X & Czech MP 2004 RNAi-based analysis of CAP, Cbl, and CrkII function in the regulation of GLUT4 by insulin. Journal of Biological Chemistry 279 37431-37435. (doi:10.1074/jbc.C400180200)
81. Molero JC, Jensen TE, Withers PC, Couzens M, Herzog H, Thien CB, Langdon WY, Walder K, Murphy MA, Bowtell DD et al. 2004 c-Cbldeficient mice have reduced adiposity, higher energy expenditure, and improved peripheral insulin action. Journal of Clinical Investigation 114 1326-1333. (doi:10.1172/JCI21480)
82. Mora A, Komander D, van Aalten DM & Alessi DR 2004 PDK1, the master regulator of AGC kinase signal transduction. Seminars in Cell and Developmental Biology 15 161-170. (doi:10.1016/j.semcdb.2003. 12.022)
83. Morris DL, Cho KW, Zhou Y & Rui L 2009 SH2B1 enhances insulin sensitivity by both stimulating the insulin receptor and inhibiting tyrosine dephosphorylation of insulin receptor substrate proteins. Diabetes 58 2039-2047. (doi:10.2337/db08-1388)
84. Nakae J, Kido Y & Accili D 2001 Distinct and overlapping functions of insulin and IGF-I receptors. Endocrine Reviews 22 818-835. (doi:10. 1210/er.22.6.818)
85. Narasimhan SD, Yen K & Tissenbaum HA 2009 Converging pathways in lifespan regulation. Current Biology 19 R657-R666. (doi:10.1016/ j.cub.2009.06.013)
86. Nelson JD, LeBoeuf RC & Bomsztyk K 2011 Direct recruitment of insulin receptor and ERK signaling cascade to insulin-inducible gene loci. Diabetes 60 127-137. (doi:10.2337/db09-1806)
87. Nishida K & Hirano T 2003 The role of Gab family scaffolding adapter proteins in the signal transduction of cytokine and growth factor receptors. Cancer Science 94 1029-1033. (doi:10.1111/j.1349-7006. 2003.tb01396.x)
88. Nouaille S, Blanquart C, Zilberfarb V, Boute N, Perdereau D, Roix J, Burnol AF & Issad T 2006 Interaction with Grb14 results in sitespecific regulation of tyrosine phosphorylation of the insulin receptor. EMBO Reports 7 512-518. (doi:10.1038/sj.embor.7400668)
89. Pearce LR, Komander D & Alessi DR 2010 The nuts and bolts of AGC protein kinases. Nature Reviews. Molecular Cell Biology 11 9-22. (doi:10.1038/nrm2822)
90. Pollak M 2008 Insulin and insulin-like growth factor signalling in neoplasia. Nature Reviews. Cancer 8 915-928. (doi:10.1038/nrc2536)
91. Pruett W, Yuan Y, Rose E, Batzer AG, Harada N & Skolnik EY 1995 Association between GRB2/Sos and insulin receptor substrate 1 is not sufficient for activation of extracellular signal-regulated kinases by interleukin-4: implications for Ras activation by insulin. Molecular and Cellular Biology 15 1778-1785.
92. Ramos JW 2008 The regulation of extracellular signal-regulated kinase (ERK) in mammalian cells. International Journal of Biochemistry and Cell Biology 40 2707-2719. (doi:10.1016/j.biocel.2008.04.009)
93. Ramos FJ, Langlais PR, Hu D, Dong LQ & Liu F 2006 Grb10 mediates insulin-stimulated degradation of the insulin receptor: a mechanism of negative regulation. American Journal of Physiology. Endocrinology and Metabolism 290 E1262-E1266. (doi:10.1152/ ajpendo.00609.2005)
94. Romanelli RJ, LeBeau AP, Fulmer CG, Lazzarino DA, Hochberg A & Wood TL 2007 Insulin-like growth factor type-I receptor internalization and recycling mediate the sustained phosphorylation of Akt. Journal of Biological Chemistry 282 22513-22524. (doi:10.1074/jbc. M704309200)
95. Rosse C, Linch M, Kermorgant S, Cameron AJ, Boeckeler K & Parker PJ 2010 PKC and the control of localized signal dynamics. Nature Reviews. Molecular Cell Biology 11 103-112. (doi:10.1038/nrm2847)
96. Sakamoto K & Holman GD 2008 Emerging role for AS160/TBC1D4 and TBC1D1 in the regulation of GLUT4 traffic. American Journal of Physiology. Endocrinology and Metabolism 295 E29-E37. (doi:10.1152/ ajpendo.90331.2008)
97. Sano H, Roach WG, Peck GR, Fukuda M & Lienhard GE 2008 Rab10 in insulin-stimulated GLUT4 translocation. Biochemical Journal 411 89-95. (doi:10.1042/BJ20071318)
98. Sasaoka T, Ishiki M, Wada T, Hori H, Hirai H, Haruta T, Ishihara H & Kobayashi M 2001 Tyrosine phosphorylation-dependent and -independent role of Shc in the regulation of IGF-1-induced mitogenesis and glycogen synthesis. Endocrinology 142 5226-5235. (doi:10.1210/en.142.12.5226)
99. Schultze SM, Jensen J, Hemmings BA, Tschopp O & Niessen M 2011 Promiscuous affairs of PKB/AKT isoforms inmetabolism. Archives of Physiology and Biochemistry 117 70-77. (doi:10.3109/13813455.2010. 539236)
100. Sehat B, Tofigh A, Lin Y, Trocme E, Liljedahl U, Lagergren J & Larsson O 2010 SUMOylation mediates the nuclear translocation and signaling of the IGF-1 receptor. Science Signaling 3 ra10. (doi:10.1126/scisignal. 2000628)
101. Shepherd PR, Withers DJ & Siddle K 1998 Phosphoinositide 3-kinase: the key switch mechanism in insulin signalling. Biochemical Journal 333 471-490.
102. Shisheva A 2008a Phosphoinositides in insulin action on GLUT4 dynamics: not just PtdIns(3,4,5)P3. American Journal of Physiology. Endocrinology andMetabolism 295 E536-E544. (doi:10.1152/ajpendo. 90353.2008)
103. Shisheva A 2008b PIKfyve: partners, significance, debates and paradoxes. Cell Biology International 32 591-604. (doi:10.1016/ j.cellbi.2008.01.006)
104. Sirvent A, Benistant C & Roche S 2008 Cytoplasmic signalling by the c-Abl tyrosine kinase in normal and cancer cells. Biology of the Cell 100 617-631.(doi:10.1042/BC20080020)
105. Slawson C, Copeland RJ & Hart GW 2010 O-GlcNAc signaling: a metabolic link between diabetes and cancer? Trends in Biochemical Sciences 35 547-555. (doi:10.1016/j.tibs.2010.04.005)
106. Smith FM, Holt LJ, Garfield AS, Charalambous M, Koumanov F, Perry M, Bazzani R, Sheardown SA, Hegarty BD, Lyons RJ et al. 2007 Mice with a disruption of the imprinted Grb10 gene exhibit altered body composition, glucose homeostasis, and insulin signaling during postnatal life. Molecular and Cellular Biology 27 5871-5886. (doi:10. 1128/MCB.02087-06)
107. Sopasakis VR, Liu P, Suzuki R, Kondo T, Winnay J, Tran TT, Asano T, Smyth G, Sajan MP, Farese RV et al. 2010 Specific roles of the p110alpha isoform of phosphatidylinsositol 3-kinase in hepatic insulin signaling and metabolic regulation. Cell Metabolism 11 220-230. (doi:10.1016/j.cmet.2010.02.002)
108. Sturgill TW 2008 MAP kinase: it's been longer than fifteen minutes. Biochemical and Biophysical Research Communications 371 1-4. (doi:10. 1016/j.bbrc.2008.04.002)
109. Sun XJ & Liu F 2009 Phosphorylation of IRS proteins Yin-Yang regulation of insulin signaling. Vitamins and Hormones 80 351-387. (doi:10.1016/S0083-6729(08)00613-4)
110. Takahashi Y, Tobe K, Kadowaki H, Katsumata D, Fukushima Y, Yazaki Y, Akanuma Y & Kadowaki T 1997 Roles of insulin receptor substrate-1 and Shc on insulin-like growth factor I receptor signaling in early passages of cultured human fibroblasts. Endocrinology 138 741-750. (doi:10.1210/en.138.2.741)
111. Taniguchi CM, Ueki K & Kahn R 2005 Complementary roles of IRS-1 and IRS-2 in the hepatic regulation of metabolism. Journal of Clinical Investigation 115 718-727. (doi:10.1172/JCI200523187)
112. Taniguchi CM, Emanuelli B & Kahn CR 2006 Critical nodes in signalling pathways: insights into insulin action. Nature Reviews. Molecular Cell Biology 7 85-96. (doi:10.1038/nrm1837)
113. Thirone AC, Huang C & Klip A 2006 Tissue-specific roles of IRS proteins in insulin signaling and glucose transport. Trends in Endocrinology and Metabolism 17 72-78. (doi:10.1016/j.tem.2006.01. 005)
114. Tups A, Anderson GM, Rizwan M, Augustine RA, Chaussade C, Shepherd PR & Grattan DR 2010 Both p110alpha and p110beta isoforms of phosphatidylinositol 3-OH-kinase are required for insulin signalling in the hypothalamus. Journal of Neuroendocrinology 22 534-542. (doi:10.1111/j.1365-2826.2010.01975.x)
115. Vardatsikos G, Sahu A & Srivastava AK 2009 The insulin-like growth factor family: molecular mechanisms, redox regulation, and clinical implications. Antioxidants & Redox Signaling 11 1165-1190. (doi:10. 1089/ars.2008.2161)
116. Vasudevan KM & Garraway LA 2010 AKT signaling in physiology and disease. Current Topics in Microbiology and Immunology 347 105-133. (doi:10.1007/82_2010_66)
117. Vecchione A, Marchese A, Henry P, Rotin D & Morrione A 2003 The Grb10/Nedd4 complex regulates ligand-induced ubiquitination and stability of the insulin-like growth factor I receptor. Molecular and Cellular Biology 23 3363-3372. (doi:10.1128/MCB.23.9.3363- 3372.2003)
118. Watson RT & Pessin JE 2007 GLUT4 translocation: the last 200 nanometers. Cellular Signalling 19 2209-2217. (doi:10.1016/j. cellsig.2007.06.003)
119. Whelan SA, Dias WB, Thiruneelakantapillai L, Lane MD & Hart GW 2010 Regulation of insulin receptor substrate 1 (IRS-1)/AKT kinase-mediated insulin signaling by O-linked beta-N-acetylglucosamine in 3T3-L1 adipocytes. Journal of Biological Chemistry 285 5204-5211. (doi:10.1074/jbc.M109.077818)
120. White MF 2002 IRS proteins and the common path to diabetes. American Journal of Physiology. Endocrinology and Metabolism 283 E413-E422. (doi:10.1152/ajpendo.00514.2001)
121. Whiteman EL, Cho H & Birnbaum MJ 2002 Role of Akt/protein kinase B in metabolism. Trends in Endocrinology and Metabolism 13 444-451. (doi:10.1016/S1043-2760(02)00662-8)
122. Wu J, Tseng YD, Xu CF, Neubert TA, White MF & Hubbard SR 2008 Structural and biochemical characterization of the KRLB region in insulin receptor substrate-2. Nature Structural and Molecular Biology 15 251-258. (doi:10.1038/nsmb.1388)
123. Yang X, Ongusaha PP, Miles PD, Havstad JC, Zhang F, So WV, Kudlow JE, Michell RH, Olefsky JM, Field SJ et al. 2008 Phosphoinositide signalling links O-GlcNAc transferase to insulin resistance. Nature 451 964-969. (doi:10.1038/nature06668)
124. Youngren JF 2007 Regulation of insulin receptor function. Cellular and Molecular Life Sciences 64 873-891. (doi:10.1007/s00018-007-6359-9)
125. Zeidan Q & Hart GW 2010 The intersections between O-GlcNAcylation and phosphorylation: implications for multiple signaling pathways. Journal of Cell Science 123 13-22. (doi:10.1242/jcs.053678)